Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

American BriVision Initiates Next Phase of Trial for ABV-1505 in Adult ADHD

americanpharmaceuticalreviewDecember 11, 2019

Tag: BriVision , ADHD , ABV-1505

PharmaSources Customer Service